Back to Portfolio

InHeart

2024

InHeat is a clinical-decision software that builds patient-specific cardiac digital twins from imaging and electrophysiology data to support arrhythmia ablation planning and improve procedural outcomes in cardiology.

Website
More details...

Company Overview

CEO
Todor Jeliaskov
INVESTED IN
2024
SECTOR
Clinical Software

Why we invested

  • CEO is a successful entrepreneur with proven execution capability
  • Strong commercial traction with meaningful turnover
  • Entry at a low valuation relative to clinical relevance and strategic value
  • Technology deeply embedded in high-value cardiology procedures
  • Clear US focus aligned with the largest electrophysiology market and acquirers